Clinical Trial: An Investigational Drug Study in Diabetics with Elevated Cholesterol


	Home	\|	Search	\|	Browse	\|	Resources	\|	Help	\|	What's New	\|	About

An Investigational Drug Study in Diabetics with Elevated Cholesterol

This study is not yet open for patient recruitment.

Sponsored by:	Merck
Information provided by:	Merck

Purpose

The purpose of this study is to evaluate the cholesterol lowering efficacy of an investigational drug in patients with Type II diabetes (high blood sugar).

Condition	Treatment or Intervention	Phase
Hypercholesterolemia Diabetes Mellitus, Type II		Phase IV

MedlinePlus related topics: Cholesterol; Diabetes

Study Type: Interventional
Study Design: Treatment, Randomized, Double-Blind, Active Control, Parallel Assignment, Safety/Efficacy Study

Eligibility

Ages Eligible for Study: 18 Years and above, Genders Eligible for Study: Both

Criteria

Inclusion Criteria:

Patients with elevated cholesterol and type II diabetes (high blood sugar)

Exclusion Criteria:

Under 18 years of age

Location Information

Toll Free Number 1-888-577-8839

Pennsylvania
Call for International Site Information, Horsham, Pennsylvania, 19044, United States

More Information

Study ID Numbers: 2004_008
Record last reviewed: October 2004
Record first received: October 1, 2004
ClinicalTrials.gov Identifier: NCT00093106
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2004-10-27

U.S. National Library of Medicine, Contact NLM Customer Service

National Institutes of Health, Department of Health & Human Services